Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Reports Higher Profit - AGNC, ALNY, ASYS, ATHN

Lakeway, NY -- (SBWIRE) -- 02/08/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

American Capital Agency Corp. (NASDAQ:AGNC) declined 0.32% to $31.10 after market trading hours. The Company announced fourth quarter results. The comprehensive income per common share comprised of $2.37 net income per common share and $(2.01) other comprehensive income per common share in the fourth quarter. The dividend per common share declared on December 14, 2012 was $1.25. The net book value per common share as of December 31, 2012 was $31.64.

How Should Investors Trade AGNC After The Recent Gain? Get Special Trend Analysis Coverage Here

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) closed at $23.84. The Company posted fourth quarter net loss of $62.2 million or $1.20 per share compared to $14.3 million or $0.33 per share in the prior year period. Net revenues from research collaborators were $8.5 million compared to $20.5 million in the previous year period. The analysts estimated a loss of $1.43 per share on revenues of $15.82 million for the quarter.

Get Latest News, Free Trend Analysis On ALNY Here

Amtech Systems, Inc. (NASDAQ:ASYS) closed at $3.96. The Company posted first quarter results.Net revenue was $9.4 million compared to $24.7 million in the first quarter of fiscal 2012. The changes reflect the continued unfavorable market conditions in the solar industry as well as lower activity in the semiconductor portion of Amtech's business. Total customer orders in the first quarter of fiscal 2013 were $5.0 million. The net loss for the first quarter of fiscal 2013 was $4.2 million or ($0.44) per share compared to net loss of $0.9 million or ($0.09) per diluted share in the prior year period.

Is ASYS a Buy After The Solid Momentum? Find Out Here

athenahealth, Inc. (NASDAQ:ATHN) closed at $88.37.The Company released fourth quarter results. Total revenue was $116.3 million compared to $92.5 million in the previous year period. GAAP net income was $5.9 million or $0.16 per diluted share compared to $5.3 million or $0.15 per diluted share in the prior year period.

Should Investors Hold ATHN After The Recent Volatile Moment? Get Special Trend Analysis Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.